Arcus Biosciences, Inc. (RCUS) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Total revenues	112.0	383.0	78.0	15.0	8.4	1.4
Total revenues growth	-70.8%	391.0%	420.0%	79.6%	491.2%
Operating expenses:
Research and development				78.5	49.6	47.2	14.2
General and administrative				25.2	13.6	7.6	3.9
Total operating expenses	392.0	329.0	202.0	103.7	63.2	54.9	18.2
Loss from operations	-252.0	56.0	-122.0	-88.7	-54.9	-53.4	-18.2
Operating margin	-225.0%	14.6%	-156.4%	-591.4%	-656.8%	-3782.1%

Non-operating income (expense):
Interest and other income, net				5.2	4.9
Total non-operating income, net	14.0	1.0	1.0	4.0	5.3	0.4	0.2
Loss before income taxes	-266.0	55.0	-123.0	-84.7
Income tax expense	-1.0	-2.0
Net loss	-267.0	53.0	-123.0	-84.7	-49.6	-53.1	-18.0
Net loss per share, basic	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net loss per share, diluted	0.0	0.0	0.0	0.0	0.0

Shares used to compute net income loss per share, basic	72.0	69.3	54.8	43.8	34.6	1.8	0.9
Shares used to compute net income loss per share, diluted	72.0	74.0	54.8	43.8	34.6